Healthequity Inc (NASDAQ:HQY) Expected to Post Quarterly Sales of $85.38 Million

Analysts forecast that Healthequity Inc (NASDAQ:HQY) will report sales of $85.38 million for the current quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Healthequity’s earnings, with estimates ranging from $83.90 million to $86.69 million. Healthequity posted sales of $71.07 million during the same quarter last year, which would indicate a positive year over year growth rate of 20.1%. The firm is scheduled to report its next earnings report on Tuesday, September 3rd.

On average, analysts expect that Healthequity will report full year sales of $343.27 million for the current fiscal year, with estimates ranging from $342.30 million to $344.38 million. For the next fiscal year, analysts expect that the firm will report sales of $391.91 million, with estimates ranging from $385.19 million to $398.50 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover Healthequity.

Healthequity (NASDAQ:HQY) last announced its quarterly earnings results on Tuesday, June 4th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.11. The company had revenue of $87.05 million during the quarter, compared to the consensus estimate of $83.98 million. Healthequity had a net margin of 30.60% and a return on equity of 14.17%.

HQY has been the subject of a number of recent research reports. JPMorgan Chase & Co. set a $80.00 price objective on Healthequity and gave the company an “overweight” rating in a report on Wednesday, June 5th. BidaskClub upgraded Healthequity from a “hold” rating to a “buy” rating in a report on Friday, July 19th. Bank of America upgraded Healthequity from a “neutral” rating to a “buy” rating and increased their price objective for the company from $75.00 to $90.00 in a report on Friday, July 19th. ValuEngine upgraded Healthequity from a “hold” rating to a “buy” rating in a report on Wednesday, July 17th. Finally, Zacks Investment Research upgraded Healthequity from a “strong sell” rating to a “hold” rating in a report on Tuesday, May 21st. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average target price of $87.92.

Shares of NASDAQ:HQY traded up $0.32 during trading on Friday, hitting $82.23. 21,444 shares of the company were exchanged, compared to its average volume of 1,473,131. The firm has a market cap of $5.11 billion, a P/E ratio of 86.56, a P/E/G ratio of 4.01 and a beta of 1.46. Healthequity has a 1-year low of $50.29 and a 1-year high of $101.58. The stock has a 50 day simple moving average of $70.73. The company has a quick ratio of 15.59, a current ratio of 15.60 and a debt-to-equity ratio of 0.07.

In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the stock in a transaction on Monday, May 20th. The shares were sold at an average price of $68.17, for a total transaction of $272,680.00. Following the completion of the transaction, the vice president now owns 64,100 shares in the company, valued at $4,369,697. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Angelique Christine Hill sold 9,500 shares of the stock in a transaction on Friday, July 12th. The shares were sold at an average price of $71.40, for a total transaction of $678,300.00. Following the transaction, the vice president now owns 15,887 shares of the company’s stock, valued at approximately $1,134,331.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 37,899 shares of company stock valued at $2,780,851. Company insiders own 3.70% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the business. Manchester Capital Management LLC bought a new position in Healthequity during the first quarter valued at $36,000. Global Retirement Partners LLC lifted its position in Healthequity by 72.7% during the first quarter. Global Retirement Partners LLC now owns 556 shares of the company’s stock valued at $41,000 after purchasing an additional 234 shares during the last quarter. Financial Gravity Wealth Inc. bought a new stake in shares of Healthequity in the 1st quarter worth about $45,000. Quantamental Technologies LLC lifted its holdings in shares of Healthequity by 5,683.3% in the 1st quarter. Quantamental Technologies LLC now owns 694 shares of the company’s stock worth $51,000 after acquiring an additional 682 shares during the last quarter. Finally, Signaturefd LLC lifted its holdings in shares of Healthequity by 24.3% in the 1st quarter. Signaturefd LLC now owns 803 shares of the company’s stock worth $59,000 after acquiring an additional 157 shares during the last quarter. Institutional investors and hedge funds own 96.50% of the company’s stock.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading: What is a growth and income fund?

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.